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The SDHD gene encodes one of the two membrane-anchoring proteins of the succinate dehydrogenase
(complex II) of the mitochondrial electron transport chain. This gene has recently been proposed to be involved
in oxygen sensing because mutations that cause loss of its function produce hereditary familiar paraganglioma,
a tumor of the carotid body (CB), the main arterial chemoreceptor that senses oxygen levels in the blood. Here,
we report the generation of a SDHD knockout mouse, which to our knowledge is the first mammalian model
lacking a protein of the electron transport chain. Homozygous SDHD/ animals die at early embryonic stages.
Heterozygous SDHD/ mice show a general, noncompensated deficiency of succinate dehydrogenase activity
without alterations in body weight or major physiological dysfunction. The responsiveness to hypoxia of CBs
from SDHD/ mice remains intact, although the loss of an SDHD allele results in abnormal enhancement of
resting CB activity due to a decrease of K conductance and persistent Ca2 influx into glomus cells. This CB
overactivity is linked to a subtle glomus cell hypertrophy and hyperplasia. These observations indicate that
constitutive activation of SDHD/ glomus cells precedes CB tumor transformation. They also suggest that,
contrary to previous beliefs, mitochondrial complex II is not directly involved in CB oxygen sensing.
Mitochondrial complex II (succinate dehydrogenase [SDH])
plays major biological roles in the Krebs cycle and the mito-
chondrial electron transport chain, oxidizing succinate to fu-
marate and transferring electrons to the ubiquinone pool (9,
12). SDH has also been proposed to have an antioxidant func-
tion, protecting against superoxide production in mitochon-
dria, and to participate in oxygen (O2) sensing (3, 7, 22, 27).
Deficiencies of any of the four subunits of SDH (A, B, C, and
D) are associated with a broad spectrum of human diseases,
ranging from myo- and encephalopathies to aging and tumor
formation. Mutations in SDHA, the matrix-faced flavoprotein,
result in dysfunction of the energy metabolism, e.g., Leigh
syndrome or exercise intolerance, whereas mutations either in
the iron-sulfur protein SDHB or in SDHC and SDHD, the
membrane-anchoring proteins that contain one heme and are
essential for ubiquinone binding, are more often associated
with pheochromocytoma and paraganglioma (1, 22, 23). Spe-
cifically, mutations in SDHD are the main cause of familiar
hereditary paraganglioma (PGL) (3) a mostly benign, highly
vascularized tumor of the carotid body (CB). SDHD is the first
tumor suppressor gene identified which encodes a mitochon-
drial protein.
The CB is the main arterial chemoreceptor that senses blood
O2 concentration. It is a highly irrigated bilateral organ, lo-
cated at the bifurcation of the carotid artery and derived from
the neural crest. Upon exposure to acute hypoxia, neurosecre-
tory CB glomus cells release transmitters which activate affer-
ent sensory fibers connected with brain stem centers to elicit
hyperventilation and sympathetic activation (see references 14
and 15 for reviews). Similar to CBs of individuals exposed
chronically to hypoxia (11, 25), PGL tumors display cellular
hyperplasia or anaplasia in the absence of hypoxic stimulus (3).
Moreover, the prevalence of paragangliomas in individuals
with SDHD mutations increases in populations living at high
altitudes (2). Thus, it has been proposed that SDHD partici-
pates in O2 sensing and that PGL tumors are induced by
defects in the detection of blood O2 levels (3, 4, 7, 22).
Advance in the study of SDH function is, however, ham-
pered by the lack of mammalian genetic models of SDH defi-
ciency. To determine the possible involvement of the mito-
chondrial complex II in O2 sensing and the pathophysiology of
hereditary CB PGL, we have generated a knockout mouse
carrying a null allele of the SDHD gene. Here we describe the
major general effects of SDHD deficiency and the physiological
features of CB glomus cells from SDHD knockout mice.
MATERIALS AND METHODS
Generation of SDHD/ knockout mice. A cDNA homolog to the human
succinate dehydrogenase D gene (accession number BF161694) was used as a
probe for the screening of a lambda FIXII vector-based genomic library of
mouse strain 129SvJ by hybridization of phage-infected bacterial plaques. Iso-
lated genomic DNA was used for making a targeting construct consisting of a neo
cassette that replaced exons 2, 3, and 4 of the SDHD gene, flanked by two arms
of homolog DNA (4.0 and 4.4 kb, respectively) that allow for homologous
recombination. The targeting construct was electroporated into mouse embry-
onic stem (ES) cells. Clones resistant to 0.2 mg of Geneticin G418 per ml were
selected and analyzed for proper targeting at the SDHD locus. Male chimeras
were generated and mated with 129SvJ wild-type females, which gave F1 off-
spring with heterozygous SDHD/ individuals. Animal care and experimenta-
tion were according to the institutional animal care committee guidelines.
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Nucleic acid analysis. Total DNA from ES cells, toe tips, and embryos was
prepared by incubation in 20 mM Tris-HCl (pH 8.5)–5 mM EDTA–1% sodium
dodecyl sulfate–400 mM NaCl–0.1 mg of proteinase K per ml at 57°C for 2 h. For
Southern blotting, 20 g of genomic DNA was digested and loaded onto a
Tris-acetate-EDTA–agarose gel. For tissue RNA analysis, organs were dissected
and homogenized in TRIzol reagent according to the manufacturer’s instruc-
tions. For Northern blotting, 10 to 15 g of RNA per sample was loaded onto a
formaldehyde-agarose gel. Electrophoresis and transfer of nucleic acids to Hy-
bond-N nylon membranes were performed by standard methods. Hybridization
was done at 42°C in Ultra-Hyb hybridization buffer. Gel-purified DNA probes
were radiolabeled with [-32P]dCTP by using the Rediprime kit.
Embryo analysis. To obtain SDHD/ embryos, heterozygous SDHD/ par-
ents were mated. Females were sacrificed at different days after copula took
place for dissection of the uterus, after which maternal tissue was carefully
removed, and embryos were dissected for DNA analysis. In order to discriminate
between the wild-type and the mutant allele a three-primer approach was de-
signed. Primers 5-TCAGTGACAACGTCGAGCAC-3, 5-CAAGGTCGGAA
CCCAGAGAT-3, and 5-ATAGCCAGCCAGGTAGTTCC-3 give products of
1.8 kb for the wild type and 1.25 kb for the mutant SDHD allele.
Isolation of mitochondria. Isolation of mitochondria from mouse tissues was
performed as reported previously (6). Tissues were dissected and washed in
ice-cold phosphate-buffered saline. The entire process of mitochondrion isola-
tion was carried out at 4°C, with samples kept on ice. Organs were cut with
scissors in small fragments in 2 ml of homogenization medium (320 mM su-
crose–1 mM EDTA–10 mM Tris-HCl [pH 7.4] for liver and kidney and 75 mM
sucrose–225 mM sorbitol–1 mM EGTA–0.1 fatty acid-free bovine serum albu-
min–10 mM Tris-HCl [pH 7.4] for brain and heart). Cells were broken with 10
to 15 strokes in a Dounce homogenizer with a motor-driven pestle. The homog-
enate was centrifuged at 4,000 rpm for 6 min in a microcentrifuge, and mito-
chondrion-containing supernatant was collected. Mitochondria were spun down
by centrifugation for 10 min at 13,000 rpm, washed twice with medium B (250
mM sucrose, 2 mM HEPES, 0.1 mM EGTA), and resuspended in a final volume
of about 250 l of medium B. The mitochondrion suspension was aliquoted (40
l), flash frozen in liquid nitrogen, and kept at 80°C until used. The protein
concentration was determined according to Bradford’s method, with samples
diluted in 0.05% sodium dodecyl sulfate.
Measurement of activities of mitochondrial complexes. Activities of mitochon-
drial complexes were determined in a Beckman DU-640 spectrophotometer, as
described by Birch-Machin and Turnbull (5) with slight modifications. All re-
agents were purchased from Sigma unless otherwise indicated. For mitochon-
drial complex I and II activities, 30 to 50 g of protein was assayed at 30°C.
Samples were diluted 1:4 in the assay reaction buffer (25 mM KH2PO4 [pH 7.2],
5 mM MgCl2, 3 mM potassium cyanide, 2.5 mg of bovine serum albumin per ml)
and freeze-thawed three times with liquid nitrogen before the assay. For mito-
chondrial complex I activity, the rotenone-sensitive NADH dehydrogenase ac-
tivity was measured as the decrease in absorbance at 340 nm, referred to 425 nm,
due to oxidation of 130 M NADH (Roche) in presence of 3.6 M antimycin
and 130 M ubiquinone-1. Absorbance was measured for 2 min before and after
addition of 5 M rotenone to the reaction mixture. During this period the rate
of decrease of absorbance was linear. Differences between rates were considered
for determining activity due to mitochondrial complex I. To evaluate the mito-
chondrial complex II activity, succinate dehydrogenase activity was measured for
a period of 2 min as the decrease in the absorbance at 600 nm due to the
reduction of 50 M 2,6-dichlorophenol-indophenol (DCPIP) coupled to reduc-
tion of 130 M ubiquinone-1. The reaction was carried out in presence of 3.6 M
antimycin, 5 M rotenone, and 10 mM succinate.
Carotid body immunohistochemistry. Bifurcations containing carotid bodies
were dissected and fixed in formalin (Sigma) at 4°C for 16 h. Tissues were
dehydrated and paraffin embedded, and 10-m slices were obtained by using an
RM2125 microtome (Leica Microsystems). Immunohistochemistry was per-
formed according to standard procedures. For detection of glomus cells, tissues
were immunostained with a rabbit polyclonal antityrosine hydroxylase (Pel-
Freez). After immunodetection with peroxidase-conjugated secondary antibody,
tissue samples were counterstained with hematoxylin.
Amperometric recordings in carotid body slices. Mouse carotid body slicing
and monitoring of single-cell secretion was done according to the same basic
procedures described for rats (18, 20). Slices were continuously perfused with a
solution containing 117 mM NaCl, 4.5 mM KCl, 23 mM NaHCO3, 1 mM MgCl2,
2.5 mM CaCl2, 5 mM glucose, and 5 mM sucrose. The normoxic solution was
bubbled with a gas mixture of 5% CO2, 20% O2, and 75% N2 (O2 tension of
150 mm Hg). The hypoxic solution was bubbled with 5% CO2 and 95% N2 to
reach an O2 tension in the chamber of 20 mm of Hg. All experiments were
done at a chamber temperature of 36°C. The cumulative secretion signal is the
sum of the time integral of successive amperometric events. The secretion rate
(in femtocoulombs per minute) was calculated as the amount of charge trans-
ferred to the recording electrode during a given time period.
Patch clamp recordings in dispersed CB glomus cells. Mouse carotid bodies
were incubated for 20 min in an enzyme solution (1 ml of phosphate-buffered
saline with 0.6 mg of collagenase II, 0.3 mg of trypsin, 40 l of elastase I, 0.3 mg
of bovine serum albumin, and 10 l of CaCl2 from a 5 mM stock solution) at
37°C, and the cells were mechanically dispersed by using fire-polished Pasteur
pipettes. Cells were plated on slivers of glass coverslips treated with poly-L-lysine
and kept in culture medium (Dulbecco’s modified Eagle’s medium with 10%
fetal bovine serum, 1% antibiotics, 1% L-glutamine, and 84 U of insulin per ml).
Macroscopic ionic currents were recorded by using the whole-cell configuration
of the patch clamp technique as adapted to our laboratory (20, 24). The standard
extracellular solution contained 117 mM NaCl, 4.5 mM KCl, 23 mM NaHCO3,
1 mM MgCl2, 2.5 mM CaCl2, 5 mM glucose, and 5 mM sucrose, and the pH was
adjusted by bubbling with 5% CO2. The standard internal solution (inside the
pipette and the cell) contained 80 mM K-glutamate, 30 mM KCl, 20 mM KF, 1
mM EGTA, and 4 mM Mg-ATP (pH 7.3) adjusted with KOH. Cell capacity was
estimated from the time integral of capacitative current transients recorded by
application of 2-ms depolarizing pulses of 20 mV from the holding potential of
80 mV. To calculate cell size, we assumed a constant membrane-specific ca-
pacity of 1 F/cm2. Conductance-voltage curves were obtained from the normal-
ized amplitude of inward K tail currents recorded at the end of depolarizing
pulses. For these experiments, we used an external solution with 30 mM KCl
(NaCl was reduced to 87 mM to maintain constant the osmolality). All of the
electrophysiological experiments were done at room temperature (22°C).
Statistical analysis. Unless otherwise specified, data are expressed as means
standard errors of the means, with the number of experiments (n) indicated.
Statistical analysis was performed with the unpaired Student t test. A P value of
0.05 was considered statistically significant.
RESULTS
Generation of the SDHD/ knockout mouse. In order to
generate a mutant allele of the SDHD gene, we first performed
a screening of a library of mouse genomic DNA, based on
lambda phage, with a cDNA probe containing the entire
SDHD coding sequence. Two fragments of approximately 16
and 19 kb were isolated. Restriction analysis and sequencing
confirmed, by comparison with the Ensembl Genome Browser
(www.ensembl.org), that they both contained the entire geno-
mic DNA corresponding to the SDHD gene. These DNA frag-
ments were used for making the targeting construct. The gen-
eration of the mutant SDHD allele is shown schematically in
Fig. 1A. The targeting construct contained the prokaryotic
neomycin resistance gene (neo) flanked by genomic DNA ho-
mologous to the SDHD locus. ES cells were electroporated
with this targeting construct and selected for Geneticin resis-
tance. ES cell clones were isolated and analyzed by Southern
blotting for proper integration of the nonfunctional allele (Fig.
1B). Homologous recombination replaced the wild-type allele
by the mutant allele lacking exons 2, 3, and 4. The selected
clones were used for blastocyst injection to generate chimeras
from which we obtained heterozygous F1 offspring, which were
also identified by Southern blotting (Fig. 1C).
Embryo lethality of SDHD/ mice. To date, we have geno-
typed 152 animals born from mating between heterozygous
parents, of which 50 (33%) were SDHD/ and 102 (66%)
were SDHD/, with no SDHD/ animals detected. These
are the relative frequencies expected for a Mendelian-type
inheritance with lethality for homozygous mutant embryos.
The analysis of embryos from heterozygous pregnant females
mated with heterozygous males indicates that SDHD/ ani-
mals die at early stages of organogenesis. Figure 2 shows that
at 7.5 days postconception (dpc) all developing embryos from
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a mating had the same appearance (Fig. 2A), whereas at 9.5
dpc approximately one-fourth of embryos were stalled at a
previous stage (Fig. 2B). To further analyze the embryonic
development of these mice, we dissected the embryos from the
maternal decidua at 7.5 dpc, among which some were clearly
arrested several hours before (Fig. 2C and D). The dissected
embryos were analyzed by PCR (Fig. 2E). The use of specific
primers for both the wild-type and mutant alleles showed that
those embryos with normal appearance (Fig. 2C) correspond-
ed to either the wild-type (SDHD/; one 1.8-kb band) or the
heterozygous (SDHD/; two bands of 1.8 and 1.25 kb) mice,
whereas the stalled embryos (Fig. 2D) corresponded to the
homozygous SDHD/ (1.25-kb band) mice. These observations
indicate that SDHD/ mutants die before 7.5 dpc in the embryo
development, coinciding with the early stage of organogenesis.
Functional analysis of the SDHD gene in heterozygous an-
imals. We analyzed the effect of the removal of one copy of the
SDHD gene on both the expression of the remaining allele and
the activity of mitochondrial complex II. In SDHD/ animals
a general decrease of the steady-state level of the SDHD
mRNA was observed in heart, brain, kidney, and liver (Fig.
3A). Consistently, in mitochondria isolated from the same tis-
sues, succinate dehydrogenase activity was 50% lower than
normal, whereas mitochondrial complex I activity remained
unchanged (Fig. 3B). Hence, the deficit of mitochondrial com-
plex II activity correlates with the absence of one of the func-
tional alleles of the SDHD gene, indicating that a compensa-
tory up-regulation of the remaining wild-type allele does not
take place. Despite the general decrease of complex II activity,
SDHD/ animals did not show signs of gross physiologic al-
terations. At 6 months, the animal weight for males was 30.8
0.7 g (n	 13) for SDHD/ animals versus 31 0.6 g (n	 22)
for SDHD/ animals; that for females was 23.4  1.1 g (n 	
11) for SDHD/ animals versus 22.7  0.5 g (n 	 13) for
SDHD/ animals.
CB glomus cell secretory activity in response to hypoxia.
The most frequent manifestation of SDHD deficiency in hu-
mans is the hereditary CB PGL (3, 4). PGL tumors display
cellular hyperplasia and CB hypertrophy, similar to what oc-
curs in individuals exposed to chronic hypoxia (11, 25). There-
fore, it has been proposed that SDHD participates in O2 sens-
ing and that the ultimate cause of PGL tumors is a defect in
sensing environmental O2 levels (3, 4, 7, 22). We have tested in
young adult mice whether a partial SDHD deficit and the re-
duction of mitochondrial complex II activity alter CB function
by monitoring catecholamine secretion from single glomus
cells in slices of the whole organ. Similar to the case for rat CB
slices (18, 20), the response to hypoxia of glomus cells in mouse
CB slices was characterized by a sharp and reversible burst of
secretory events (Fig. 4A). This response was maintained, or
FIG. 1. (A) Generation of a null allele of the SDHD gene. Gene targeting replaced the wild-type allele by a nonfunctional allele lacking exons
2, 3, and 4. The two homologous fragments of genomic DNA (4.0 and 4.4 kb) flanking the prokaryotic neomycin resistance (neo) gene allow for
homologous recombination. B, BamHI; H, HindIII. (B) Selected ES cell clones were analyzed for correct gene targeting at the SDHD locus by
Southern blotting. Digested DNA was hybridized with the indicated probes, giving additional bands of the indicated sizes in the heterozygous
(/) ES clone with respect to the homozygous wild type (/). (C). Southern blot genotyping of SDHD knockout mice.
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even augmented, in SDHD/ mice (Fig. 4B and C), indicating
that a partial deficiency of complex II activity does not alter
glomus cell responsiveness to hypoxia. However, spontaneous
CB activity under normoxic conditions was increased by 2.4-
fold (P  0.05) in SDHD/ animals compared with wild-type
littermates (Fig. 4D). The higher resting excitability of CB
cells in SDHD/ animals also explained the slight increase of
the hypoxic response. The spontaneous secretory activity of
SDHD/ glomus cells was reversibly abolished by blockade of
Ca2 channels with Cd2 (Fig. 4E), thus suggesting that it was
due to persistent extracellular Ca2 influx through membrane
channels (18, 20, 24).
Electrophysiological and morphological characterization of
CB glomus cells in SDHD/mice. To analyze in further detail
the molecular changes underlying CB activation in SDHD/
mice, we studied the K currents in patch-clamped glomus
cells, as it is known that in this preparation K channels reg-
ulate membrane potential and cellular excitability (see refer-
ence 20 and references therein). Representative families of K
currents from SDHD/ and SDHD/ glomus cells are illus-
trated in Fig. 5A and B. The average K current density- and
conductance-voltage relationships are shown in Fig. 5C and D,
respectively. In wild-type glomus cells the increase in K cur-
rent amplitude induced by membrane depolarization showed a
characteristic saturation at positive membrane potentials (Fig.
5A and C). This reflects a K current component mediated by
voltage- and Ca2-activated K channels whose probability of
being open decreases at membrane voltages near the apparent
Ca2 equilibrium potential (16, 21). Interestingly, under the
experimental conditions of our study, this current component
almost disappeared in glomus cells from SDHD/ mice (Fig.
5B). In SDHD/ glomus cells, the K current-voltage rela-
tionship was almost linear (Fig. 5C), and the total K current
density decreased (3.55  0.63 pA/m2 [n 	 11] for SDHD/
mice and 2.96  0.11 pA/m2 [n 	 8] for SDHD/ mice at
20 mV). In addition, close inspection of the macroscopic K
current recordings indicated that their activation threshold
increased in SDHD/ glomus cells (compare the current
records obtained at 30, 20, and 10 mV in Fig. 5A and B).
This was confirmed by the analysis of the K conductance-
voltage relationships, which demonstrated a10-mV displace-
ment to positive membrane potentials of the activation thresh-
old of K channels in SDHD/ glomus cells (Fig. 5D).
Although a complete biophysical analysis of ion channels in
SDHD/ glomus cells is outside the scope of the present
study, the data suggest that the sensitivity to Ca2 of K
channels could be decreased in SDHD-deficient animals. It is
known that Ca2-activated K channels contribute to the rest-
ing potential of rodent glomus cells (20, 26) and that in most
tissues these channels act as counterregulatory devices that
prevent excessive cell depolarization. Therefore, the biophys-
ical changes observed in patch-clamped SDHD/ glomus cells
could account for the persistent secretory activity detected by
amperometry in CB slices.
The constitutive functional activation of CB glomus cells
observed in SDHD-deficient mice occurred without obvious
FIG. 2. (A and B) Embryos dissected at (A) 7.5 dpc and (B) 9.5 dpc from SDHD/ females mated with SDHD/ males. Note differences
between embryos in panel B, which are not observable in panel A. (C and D) Embryos dissected from maternal decidua at 7.5 dpc. (E) PCR
analysis of embryos dissected at 7.5 dpc. Stalled embryos show only the band corresponding to the mutant SDHD allele (/; 1.25 kb), whereas
normal embryos show the pattern expected for either wild-type (/; 1.8 kb) or heterozygous (/; both bands) individuals.
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organ enlargement or gross histological modifications. How-
ever, the glomus cell membrane surface (estimated from the
values of cell capacitance measured in patch-clamped cells)
increased from 254  57 m2 (n 	 25) in wild-type to 297 
17 m2 (n	 17) in SDHD/ glomus cells (P 0.05). We have
also observed a slight, although significant, increase in the
percentage of glomus cells, identified by their immunoreactiv-
ity to tyrosine hydroxylase (TH), that exist in CBs of female
SDHD/ (44.3  1.3%; n 	 4) compared with SDHD/
(37.8  1.5%; n 	 3) animals (Fig. 6). The subtle glomus cell
hyperplasia and organ hypertrophy probably precede tumor
transformation, although we so far have not observed CB tu-
mors in SDHD/ mice. In humans, loss of heterozygosity
(LOH) of the wild-type allele is required for PGL to occur (3,
4). The absence of tumors in the SDHD/ mice suggests that
the induction of LOH in CB glomus cells depends on different
factors in humans and rodents. However, since systematic oc-
currence of pathologies associated with complex II deficiency
depends on age (23), the possibility that CB paragangliomas
could appear in aged SDHD/ mice cannot be ruled out.
DISCUSSION
We report here a mammalian genetic model of SDH defi-
ciency. To our knowledge, this is the first knockout mouse for
a component of the mitochondrial electron transport chain.
We show that the complete lack of the SDHD subunit is lethal
during embryonic development and that partial SDHD defi-
ciency produces a 50% generalized decrease of the mito-
chondrial complex II activity, as determined by enzymatic assay
of succinate dehydrogenase activity in isolated mitochondria. It
has been shown that mutation of the SDHC homolog in Cae-
norhabditis elegans results in 
80% reduction of complex II
activity (10). The null C. elegans mutant is to some extent
viable due to a small remaining SDH activity. Interestingly, this
is not the case for the SDHD knockout mouse model, where
the complete absence of the gene prevents embryo develop-
ment. Lethality occurs in the early stages of organogenesis,
most likely between 6.5 and 7.5 dpc, possibly due to the high
energetic demands of embryos and/or to the general metabolic
modifications resulting from the accumulation of succinate.
We have not observed in the heterozygous SDHD/ mouse a
gene dosage compensation by overexpression of the wild-type
allele. It is noteworthy that this functional deficit was similar in
FIG. 3. (A) SDHD mRNA expression in the indicated tissues. To-
tal RNA was hybridized with an SDHD cDNA-containing probe. The
Ppia gene, encoding cyclophilin, was used as loading control. (B) Mito-
chondrial succinate-dehydrogenase (MCII) and NADH-dehydroge-
nase (MCI) activities in mouse tissues. Data are the averages from four
animals per tissue and genotype. Error bars indicate the standard error. In
all tissues MCII activities in SDHD/ and SDHD/ mice were signifi-
cantly different (P  0.05). Numbers in parentheses indicate the rel-
ative activity (in percent) in SDHD/ with respect to SDHD/ mice.
FIG. 4. Secretory activity and responsiveness to hypoxia of CB
cells. (A and B) Secretory response to hypoxia of CB cells of SDHD/
(A) and SDHD/ (B) mice. Spike-like quantal events correspond to
catecholamine release from individual vesicles. Cumulative secretion
(in femtocoulombs) for each experiment is shown. (C) Quantification
of the secretory response to low O2 tension (in femtocoulombs/last
minute of hypoxia) in SDHD-deficient (5,105  810 fC/min [mean 
standard error]; n 	 16) and wild-type (3,539  603 fC/min; n 	 18)
mice (P 	 0.12 by analysis of variance). (D) Quantification of the
spontaneous secretory activity in CB slices from SDHD/ (462  94
fC/min [mean  standard error]; n 	 16) and wild-type (198  35
fC/min; n 	 18) mice (P 	 0.01 by the Kruskal-Wallis test). (E) Spon-
taneous secretory activity in a SDHD/ CB cells and reversible block-
ade by application of 0.3 mM extracellular cadmium.
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tissues with relatively high (heart or kidney) and low (liver and
brain) levels of SDH activity, pointing to a generalized deficit
of succinate dehydrogenase activity. Strikingly, this SDH defi-
ciency did not produce any gross morphological alteration or
changes in body weight in SDHD/ animals. Whether the
existing mitochondrial SDH activity is sufficient to meet the
metabolic demands of the tissues in vivo or whether there is a
systemic compensation of SDH activity that is not detectable in
FIG. 5. Macroscopic K currents in patch-clamped dispersed glomus cells of wild-type and partially SDHD-deficient mice. (A and B) Families
of representative outward K currents in SDHD/ and SDHD/ glomus cells recorded during 100-ms depolarizing pulses reaching membrane
potentials between 30 and 60 mV in steps of 10 mV. (C) K current density (ordinate)-versus-voltage (abscissa) relationship in wild-type and
SDHD/ glomus cells. Each point is the average from at least eight different experiments. (D) Normalized K conductance (ordinate)-versus-
voltage (abscissa) relationship in wild-type and SDHD/ glomus cells. Each point is the average from at least three different experiments. Data
points were fitted by an equation of the form G 	 1/[1  exp(V1/2  Vm)/k]. The half activation (V1/2) (11.7 and 10.6 mV for SDHD
/ and
SDHD/, respectively) and the slope factor (k) (14.6 and 12.6 mV for SDHD/ and SDHD/, respectively) were similar for the two curves.
However, the activation threshold was clearly higher in SDHD/ glomus cells (inset in panel D). In panels C and D, error bars are omitted.
FIG. 6. (A and B) Immunohistochemistry of SDHD/ (A) and SDHD/ (B) carotid bodies. Tissues were incubated with an antibody to TH
after which they were counterstained with hematoxylin for counting of nuclei. Note the cluster organization of glomus cells. (C) Percentage of
TH-positive cells in the CBs of female mice (n 	 3 for SDHD/; n 	 6 for SDHD/). The asterisk indicates statistical significance (P  0.05).
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the mitochondrial assay are questions that remain to be inves-
tigated.
Detailed analysis of CB function in SDHD/ animals has
allowed us to detect a persistent CB overstimulation that re-
sembles the Ca2-dependent CB activation induced by phar-
macological inhibition of the mitochondrial electron transport
chain (18). Electrophysiological studies on glomus cells suggest
that a subtle, but measurable, decrease in the density and
activation threshold of Ca2-dependent K channels in
SDHD/ individuals could account for the persistent secre-
tory activity of CB cells. However, future experiments should
address how defects in SDHD activity lead to K channel
dysfunction. In this respect, it is tempting to speculate that
formation of reactive oxygen species at complex II might play
a role, as has been proposed for hypoxic pulmonary vascula-
ture (19), but this has yet to be shown in SDHD/ mice.
The functional changes observed in SDHD/ CB cells are
not accompanied by major histological modifications. We have
detected an increase in the SDHD/ glomus cell membrane
surface, which could reveal some degree of cell hypertrophy.
Immunohistochemical studies have also shown a small but
significant increase in the percentage of TH-positive cells in
the CBs of female SDHD/ mice with respect to wild-type
animals. Whether this is due to an increase in the expression of
TH or to proliferation of glomus cells is unknown. Neverthe-
less, increases either in cell volume and number or in TH
expression are hallmarks of hypoxia-induced CB hypertrophy
(25). The constitutive CB overstimulation, which implies a
constant Ca2 influx and the activation of Ca2-dependent
biochemical events in CB cells, is probably one of the mecha-
nisms that induce first cellular hypertrophy and hyperplasia
and subsequently tumor transformation in SDHD/ patients.
The fact that hereditary PGL shares histological characteristics
with CBs exposed to chronic hypoxia (3, 4) and the higher fre-
quency of SDHD mutant alleles in populations living at low alti-
tudes (2) have led to the suggestion that SDHD participates in
CB responses to lowering O2 tension. We have shown that CB
responsiveness to hypoxia was not impaired in the mutant
SDHD/ mice despite a 50% generalized decrease in SDH ac-
tivity, and persistent CB overstimulation was observed. Although
it has not yet been possible to test the responsiveness to hypoxia
of SDHD/ glomus cells, the data available so far suggest that
SDHD is not directly responsible for CB acute O2 sensing.
Tumor formation in hereditary CB PGL appears to require
the LOH of the SDHD wild-type allele. To date, we have not
observed an increased susceptibility to tumorigenesis in our
mouse model. Thus, it is likely that the biological determinants
making the human SDHD region a hot spot for LOH do not
exist in mouse. On the other hand, the rate of PGL tumor
onset, like that of most of the pathologies associated with
mitochondrial complex II deficiencies, depends on age (1, 22,
23). Since the average age of the mice in our colony does not
reach 1 year, we cannot exclude the possibility that tumors will
appear in aged mice. As in the CB, somatic SDHD deficiency
could also produce constitutive subclinical alterations in other
organs, especially in those containing paraneural tissues, where
the decrease of complex II activity precedes the appearance of
diseases (8, 13, 17). The SDHD knockout mouse model could
help to provide prognostic insights for individuals carrying
mutations. In addition, it could be a valuable tool for the study
of the pathophysiological mechanisms that induce LOH-de-
pendent tumorigenesis and other pathologies associated with
SDHD deficiency in humans.
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